Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Determination of the hemoglobin F program in human progenitor-derived erythroid cells.
A D Friedman, … , J Javid, D G Nathan
A D Friedman, … , J Javid, D G Nathan
Published April 1, 1985
Citation Information: J Clin Invest. 1985;75(4):1359-1368. https://doi.org/10.1172/JCI111837.
View: Text | PDF
Research Article Article has an altmetric score of 3

Determination of the hemoglobin F program in human progenitor-derived erythroid cells.

  • Text
  • PDF
Abstract

The absolute adult and fetal hemoglobin (HbF) contents of the erythroid cells derived from the differentiation of normal human and simian erythroid progenitors and of the peripheral blood erythroid burst-forming units (BFU-E) of patients with nondeletion hemoglobinopathies have been measured with a sensitive radioligand immunoassay. The HbF content varied between 0.13 and 2.96 pg/cell, representing between 0.7% and 19.6% of the total hemoglobin with a mean value of 7.0%. The absolute content of HbF was indistinguishable in the well-hemoglobinized progeny of marrow erythroid colony-forming units, marrow or blood BFU-E, or of mixed colony-forming units. The term HbF program refers to this inherent capacity to produce fetal hemoglobin (HbF) in the erythroid cells derived from these progenitors in vitro. The HbF content of marrow erythroblasts as determined by the same radioligand immunoassay was similar to that found in the peripheral blood, suggesting that the switch off of gamma-chain production occurs after the erythroid colony-forming unit stage of maturation. Increasing concentrations of a crude erythropoietin-containing preparation induced higher numbers of erythroid colonies, which were larger in size, but the HbF program was unaffected. In contrast to the hemoglobin accumulation in human progenitor-derived colonies, simian progenitor-derived colonies produced considerably more HbF, and the amount of HbF was strongly influenced by progenitor maturity. Assays of the HbF content of erythroblasts derived from culture of the peripheral blood BFU-E of patients with nondeletion hemoglobinopathies and their parents showed that the HbF program in the progenitors of such patients is highly variable. Some produce only a slight excess of HbF in progenitor-derived erythroblasts, whereas others have extraordinarily high HbF programs. The molecular basis of this variability is presently unknown.

Authors

A D Friedman, D C Linch, B Miller, J M Lipton, J Javid, D G Nathan

×

Total citations by year

Year: 2015 2001 1993 1990 1989 1987 1986 Total
Citations: 1 1 1 2 2 2 1 10
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (10)

Title and authors Publication Year
Human primary erythroid cells as a more sensitive alternative in vitro hematological model for nanotoxicity studies: Toxicological effects of silver nanoparticles
N Rujanapun, S Aueviriyavit, S Boonrangsiman, A Rosena, D Phummiratch, S Riolueang, N Chalaow, V Viprakasit, R Maniratanachote
Toxicology in Vitro 2015
Fetal and maternal progenitor cells in co-culture respond equally to erythropoietin
RM Bohmer, KL Johnson, DW Bianchi
Prenatal Diagnosis 2001
A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders
SP Perrine, GD Ginder, DV Faller, GH Dover, T Ikuta, HE Witkowska, S Cai, EP Vichinsky, NF Olivieri
New England Journal of Medicine 1993
Interferon-γ Modulates Fetal Hemoglobin Synthesis in Sickle Cell Anemia and Thalassemia
BA Miller, N Olivieri, SM Hope, DV Faller, SP Perrine
Journal of Interferon Research 1990
Pharmacologic Manipulation of Fetal Hemoglobin in the Hemoglobinopathies
DG Nathan
Annals of the New York Academy of Sciences 1990
Saudi Arabian Sickle Cell Anemia
BA Miller, M Salameh, M Ahmed, N Olivieri, TH Huisman, SH Orkin, DG Nathan
Annals of the New York Academy of Sciences 1989
Application of high-performance liquid chromatographic methodology to the analysis of hemoglobins synthesized in erythroid progenitor cells
K Bhaumik, TH Huisman
Journal of Chromatography B: Biomedical Sciences and Applications 1989
Human Ontogenic Development: Studies on the Hemopoietic System and the Expression of Homeo Box Genes
C Peschle
Annals of the New York Academy of Sciences 1987
Butryic acid analogues augment γ globin gene expression in neonatal erythroid progenitors
SP Perrine, BA Miller, MF Greene, RA Cohen, N Cook, C Shackleton, DV Faller
Biochemical and Biophysical Research Communications 1987
Investigations of the simian ontogenic switch from fetal to adult hemoglobin at the progenitor cell level
BP Alter, RS Weinberg, DC Linch, JM Schofield, BT Jackson, GJ Piasecki, JC Thornton, DG Nathan
Journal of Clinical Investigation 1986

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
9 readers on Mendeley
See more details